Experimental drug to fight flu

by Medindia Content Team on  April 1, 2002 at 6:02 PM General Health News
RSS Email Print This Page Comment
Experimental drug to fight flu
RECENT research has shown that new compounds developed for preventing and treating the flue have shown promise in animal studies, and may require only one dose to be effective. The compounds, known collectively as multimeric zanamivir, are based on the existing flu drug relenza, or zanamivir, which the U.S. Food and Drug administration approved in 1999 for treating influenza A and B.
Advertisement

Researchers reported at the International Conference on Antiviral Research in Prague that a single dose of multimeric zanamivir successfully treated mice infected with human influenza A and B.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Flu Swine Flu 
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive